Business Context and Reporting Period
This Form 8-K, dated December 14, 2025, reports that Canopy Growth Corporation (CGC) entered into a definitive Arrangement Agreement to acquire MTL Cannabis Corp. (MTL). The transaction is structured as a plan of arrangement under the Canada Business Corporations Act. Closing is expected by the end of February 2026, subject to regulatory, court, and shareholder approvals.
Key Financial Metrics and Transaction Terms
- Consideration: MTL shareholders will receive 0.32 of a Canopy Growth Share and C$0.144 in cash for each MTL Share.
- Total Aggregate Value: Approximately 38 million Canopy Growth Shares and C$17 million in cash (based on non-diluted MTL shares).
- Additional Issuance: Up to 2,956,391 Canopy Growth Shares will be issued to former Montreal Cannabis Medical, Inc. shareholders in exchange for the release of anti-dilution claims.
- Termination Fee: MTL is obligated to pay a C$4,000,000 termination fee under specific circumstances, including failure to obtain shareholder approval or a change of recommendation.
- Financial Statements: The filing incorporates MTL's audited financial statements for years ended March 31, 2025 and 2024, and unaudited interim statements for periods ended September 30, 2025. Canopy Growth's specific revenue, profit, or cash flow metrics for the reporting period are not detailed in this filing.
Material Changes and Conditions
The primary material change is the proposed acquisition of MTL. The transaction is subject to several material conditions precedent:
- Approval by the Supreme Court of British Columbia.
- Approval by MTL shareholders (requiring a two-thirds vote of shares present and a simple majority excluding certain related parties).
- Regulatory approvals under the Competition Act (Canada) and the Toronto Stock Exchange.
- Exemption from U.S. Securities Act registration requirements under Section 3(a)(10).
- Deposit of consideration into escrow and payment of transaction expenses.
Guidance, Outlook, and Management Commentary
Outlook and Timeline: Canopy Growth anticipates closing the Arrangement by the end of February 2026, assuming timely receipt of all necessary approvals. The "Outside Date" for termination is April 15, 2026.
Management Changes:
- Michael Perron: Appointed as Chief Operating Officer of Canopy Growth effective upon closing. His compensation includes a C$450,000 base salary, a discretionary bonus up to 40% of base, long-term incentives, and a retention bonus equal to 12 months of base salary.
- Founders: Richard and Michel Clement will enter into 18-month consulting agreements with C$25,000 monthly fees and performance stock units valued at C$2,000,000 each.
Risks and Contingencies: The filing highlights significant risks including the dilutive impact of the transaction, potential negative effects on share price from future resales by MTL shareholders, regulatory hurdles in the cannabis industry, and macroeconomic factors such as inflation and interest rates. There is no assurance the transaction will close.
Investor Verification Checklist
- Verify the final approval status of the Arrangement by the Supreme Court of British Columbia and MTL shareholders.
- Confirm the exact number of Canopy Growth Shares to be issued, as the 38 million figure is based on a non-diluted basis and may change.
- Review the audited financial statements of MTL (Exhibits 99.3 and 99.4) to assess the target's financial health and liabilities.
- Monitor the status of regulatory approvals under the Competition Act and the Toronto Stock Exchange.
- Assess the potential dilution impact on existing Canopy Growth shareholders from the issuance of approximately 38 million new shares plus additional shares for claim releases.